Literature DB >> 10591317

Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax.

A M Friedlander1, P R Pittman, G W Parker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10591317     DOI： 10.1001/jama.282.22.2104

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  35 in total

1.  Early statistical detection of anthrax outbreaks by tracking over-the-counter medication sales.

Authors:  Anna Goldenberg; Galit Shmueli; Richard A Caruana; Stephen E Fienberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

Review 2.  The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance.

Authors:  Mark V Rubertone; John F Brundage
Journal:  Am J Public Health       Date:  2002-12       Impact factor: 9.308

3.  Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge.

Authors:  Sherry R Crowe; Linda L Ash; Renata J M Engler; Jimmy D Ballard; John B Harley; A Darise Farris; Judith A James
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

Review 4.  [Bioterrorism and primary care].

Authors:  M A Mayer Pujadas; M J Alvarez Pasquín; J Gómez Marco; J Redondo Sánchez; J Muñoz Gutiérrez; M Cereceda Ferrés; C Batalla Martínez; E Comín Bertrán; A Pareja Bezares; R Piñeiro Guerrero; V Niño Martín; J Arranz Izquierdo; P Carceller; E Nodar Martín; J Ortega Martínez; J Vázquez Villegas
Journal:  Aten Primaria       Date:  2002-10-15       Impact factor: 1.137

Review 5.  Development of an improved vaccine for anthrax.

Authors:  Stephen H Leppla; John B Robbins; Rachel Schneerson; Joseph Shiloach
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

6.  Inhalational anthrax: radiologic and pathologic findings in two cases.

Authors:  Bradford J Wood; Bryan DeFranco; Mary Ripple; Martin Topiel; Carlos Chiriboga; Venkat Mani; Kevin Barry; Dave Fowler; Henry Masur; Luciana Borio
Journal:  AJR Am J Roentgenol       Date:  2003-10       Impact factor: 3.959

7.  Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax.

Authors:  Sandip K Datta; Mojgan Sabet; Kim Phung L Nguyen; Patricia A Valdez; Jose M Gonzalez-Navajas; Shamima Islam; Ivan Mihajlov; Joshua Fierer; Paul A Insel; Nicholas J Webster; Donald G Guiney; Eyal Raz
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

8.  Identification of a protein subset of the anthrax spore immunome in humans immunized with the anthrax vaccine adsorbed preparation.

Authors:  Indira T Kudva; Robert W Griffin; Jeonifer M Garren; Stephen B Calderwood; Manohar John
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

9.  Chemical synthesis and immunological properties of oligosaccharides derived from the vegetative cell wall of Bacillus anthracis.

Authors:  Mahalakshmi Vasan; Jana Rauvolfova; Margreet A Wolfert; Christine Leoff; Elmar L Kannenberg; Conrad P Quinn; Russell W Carlson; Geert-Jan Boons
Journal:  Chembiochem       Date:  2008-07-21       Impact factor: 3.164

10.  Cost-effectiveness comparison of response strategies to a large-scale anthrax attack on the chicago metropolitan area: impact of timing and surge capacity.

Authors:  Demetrios N Kyriacou; Debra Dobrez; Jorge P Parada; Justin M Steinberg; Adam Kahn; Charles L Bennett; Brian P Schmitt
Journal:  Biosecur Bioterror       Date:  2012-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.